Clinical study on the efficacy and safety assessment of BlephEx treatment for blepharitis and meibomian gland dysfunctio
- Conditions
- blepharitis and meibomian gland dysfunction
- Registration Number
- JPRN-jRCT1092220338
- Lead Sponsor
- Ishinkai Group Niimi Eye Istitute
- Brief Summary
Improvement of meibomian gland infarction and improvement of eyelash and eyelash root contamination were observed by BlephEx treatment, but the feeling of dryness of eyes was not completely cured in the case of contact wearer. Moreover, it was found that cosmetic contaminations of eyelashes and eyelid margins with mascara and eyebrows are easier to remove with BlephEx treatment if washed out to some extent before BlephEx treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- PENDING
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Patients who are 18 years of age or older who are suspected of blepharitis or meibomian gland dysfunction
Exclusion Criteria
Patients with acute conjunctivitis, severe allergy, eyelid cleft wound, corneal structural vulnerability
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Amount of debris of the eyelashes root
- Secondary Outcome Measures
Name Time Method Meibomian gland infarction